THERE'S AN ALTERNATIVE TO WARFARIN
FOR PEOPLE WHO NEED ONE. IT'S CALLED WATCHMAN™.
A one-time procedure that effectively reduces the risk of stroke in patients with non-valvular atrial fibrillation.See How It Works
Explore our breakthrough products that make a meaningful difference in patient's lives.
Discover resources for Cardiovascular, Gastroenterology and Urology administrators.
Learn about living with an implanted device, explore health conditions and treatment options, and get support.
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
Boston Scientific Announces Agreement to Acquire Apama Medical
Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic
Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic
Real-World Data Confirms Long-Term Effectiveness Of Bronchial Thermoplasty
Boston Scientific Announces Results for Second Quarter 2017
Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day
Boston Scientific Receives CE Mark for Vercise™ Gevia™ Deep Brain Stimulation System
Boston Scientific Announces Positive Outcomes From Prospective Study Of Bronchial Thermoplasty